Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Three-Test Panel Launched for Detection of Liver Fluke Infections

By LabMedica International staff writers
Posted on 23 Feb 2026

Parasitic liver fluke infections remain endemic in parts of Asia, where transmission commonly occurs through consumption of raw freshwater fish or aquatic plants. More...

Chronic infection is a well-established risk factor for cholangiocarcinoma, a rare but highly aggressive bile duct cancer, highlighting the need for accurate, targeted diagnostics. A newly launched three-test panel addresses this gap by enabling serologic detection of the major human liver fluke species.

Kephera Diagnostics (Framingham, MA, USA) has announced the introduction of the first commercial testing panel for liver fluke infections in the United States, offered through its CLIA-certified laboratory. The panel includes assays for Clonorchis sinensis (Chinese liver fluke), Opisthorchis viverrini (Southeast Asian liver fluke), and Fasciola hepatica (common liver fluke). The company previously received USD 2.3 million in Small Business Innovation Research (SBIR) funding from the National Institutes of Health to support development of the assays.

The panel detects antibodies to parasite-specific biomarkers using an enzyme-linked immunosorbent assay (ELISA) format. As a serological approach, it can identify evidence of both current and past infections. The offering is positioned as unique in the United States, with no tests for Clonorchis or Opisthorchis liver fluke infection currently available from the U.S. Centers for Disease Control and Prevention or other laboratories.

Infection with Chinese and Southeast Asian liver flukes is endemic across large regions of Asia, with estimates of up to 45 million people infected. Long-term infection with these species has been associated with cholangiocarcinoma and they are among the few parasites designated biological carcinogens by the World Health Organization. Fasciola hepatica is transmitted via aquatic plants such as watercress and is found worldwide, with between 2.4 million and 17 million people thought to be infected, particularly where sheep and cattle are raised.

“The launch of the liver fluke panel from our CLIA laboratory is a significant step forwards for public health as well as for Kephera,” said Andrew Levin, PhD, Chief Executive and Scientific Officer of Kephera Diagnostics. “It fills a known gap in diagnostics for these parasites, which have been underrecognized sources of illness due to the lack of available testing resources up until now.”.

Related Links
Kephera Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.